These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34944718)
1. Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril. Jasenovec T; Radosinska D; Kollarova M; Balis P; Dayar E; Bernatova I; Zorad S; Vrbjar N; Cacanyova S; Radosinska J Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944718 [TBL] [Abstract][Full Text] [Related]
2. The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760. Cacanyiova S; Cebova M; Simko F; Baka T; Bernatova I; Kluknavsky M; Zorad S; Krskova K; Shaman E; Zemancikova A; Barta A; Aydemir BG; Berenyiova A Biol Res; 2023 Oct; 56(1):55. PubMed ID: 37875978 [TBL] [Abstract][Full Text] [Related]
3. Effects of Taxifolin in Spontaneously Hypertensive Rats with a Focus on Erythrocyte Quality. Jasenovec T; Radosinska D; Kollarova M; Balis P; Zorad S; Vrbjar N; Bernatova I; Cacanyiova S; Tothova L; Radosinska J Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556410 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril. Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA Br J Pharmacol; 2009 Dec; 158(8):1911-21. PubMed ID: 19917062 [TBL] [Abstract][Full Text] [Related]
5. Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760-Benefit or Detriment in Essential Hypertension? Berenyiova A; Bernatova I; Zemancikova A; Drobna M; Cebova M; Golas S; Balis P; Liskova S; Valaskova Z; Krskova K; Zorad S; Dayar E; Cacanyiova S Biomedicines; 2021 Dec; 10(1):. PubMed ID: 35052717 [TBL] [Abstract][Full Text] [Related]
6. Ultra-Small Superparamagnetic Iron-Oxide Nanoparticles Exert Different Effects on Erythrocytes in Normotensive and Hypertensive Rats. Radosinska J; Jasenovec T; Radosinska D; Balis P; Puzserova A; Skratek M; Manka J; Bernatova I Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33918438 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte sodium ion transport system in DOC-salt, Goldblatt, and spontaneously hypertensive rats. Yokomatsu M; Fujito K; Numahata H; Koide H Scand J Clin Lab Invest; 1992 Oct; 52(6):497-506. PubMed ID: 1329186 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. Gowrisankar YV; Clark MA J Neurochem; 2016 Jul; 138(1):74-85. PubMed ID: 27085714 [TBL] [Abstract][Full Text] [Related]
9. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan. Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080 [TBL] [Abstract][Full Text] [Related]
10. Alterations in Antioxidant Status and Erythrocyte Properties in Children with Autism Spectrum Disorder. Jasenovec T; Radosinska D; Jansakova K; Kopcikova M; Tomova A; Snurikova D; Vrbjar N; Radosinska J Antioxidants (Basel); 2023 Nov; 12(12):. PubMed ID: 38136174 [TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. Bucci M; Vellecco V; Cantalupo A; Brancaleone V; Zhou Z; Evangelista S; Calderone V; Papapetropoulos A; Cirino G Cardiovasc Res; 2014 Apr; 102(1):138-47. PubMed ID: 24501330 [TBL] [Abstract][Full Text] [Related]
12. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition. Gómez-Roso M; Montero MJ; Carrón R; Sevilla MA J Pharm Pharmacol; 2016 Nov; 68(11):1422-1429. PubMed ID: 27670145 [TBL] [Abstract][Full Text] [Related]
13. MLN-4760 Induces Oxidative Stress without Blood Pressure and Behavioural Alterations in SHRs: Roles of Kluknavsky M; Micurova A; Cebova M; Şaman E; Cacanyiova S; Bernatova I Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552591 [TBL] [Abstract][Full Text] [Related]
14. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786 [TBL] [Abstract][Full Text] [Related]
15. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats. Javkhedkar AA; Lokhandwala MF; Banday AA Am J Physiol Renal Physiol; 2012 Jan; 302(1):F47-51. PubMed ID: 21900450 [TBL] [Abstract][Full Text] [Related]